Goldman Further Sweetens Terms on Loan for DuPont Unit’s Sale

Goldman Sachs Group Inc. sweetened terms further on a downsized $1.25 billion of financing tied to chemical maker Arclin Inc.’s acquisition of DuPont de Nemours Inc.’s Aramids business amid ongoing struggles for leveraged loans....

Redirecting to full article...